Latest News

Glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life, study suggests

Many glioblastoma patients treated with bevacizumab (AvastinŽ) have significant deterioration in neurocognitive function, symptoms and quality of life.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • New model for identifying total hip replacement candidates

  • Challenging students benefit from limit setting

  • Brain signals contain the code for your next move

  • 'Do' is better than 'don't' when it comes to eating better

  • Study identifies brain regions activated when pain intensity doesn't match expectation

  • Millennials: The least religious generation

  • Medical, magnetic millirobots offer hope for less-invasive surgeries

  • Differences in RORA levels in brain may contribute to autism sex bias

  • Homely men who misbehave can't win for losing: Attractiveness influences online daters, jurors

  • Imaging test may identify biomarker of Alzheimer's disease

  •